Literature DB >> 21653740

Identification of antigenic targets for immunodetection of Balamuthia mandrillaris infection.

Zuzana Kucerova1, Rama Sriram, Patricia P Wilkins, Govinda S Visvesvara.   

Abstract

The free-living amoeba Balamuthia mandrillaris causes granulomatous amoebic encephalitis (GAE) in humans. Rapid identification of balamuthiasis is critical for effective therapeutic intervention and case management. In the present study we identified target antigens for the development of a serological assay for B. mandrillaris infection. We demonstrated by silver staining that protein profiles for all eight isolates of B. mandrillaris, independent of human or animal origin or geographic origin, appeared to be similar except for some minor differences, indicating the molecular homogeneity of these strains. The profiles of all isolates, which ranged from 200 to 10 kDa, were similar, with a prominent protein visible around 30 kDa; all appeared considerably different from protein profiles of the control E6 cells and Acanthamoeba castellanii and Naegleria fowleri isolates. Western blot analysis with rabbit hyperimmune serum identified the major immunodominant antigens of 25, 50, 75, and 80 kDa; positive human sera reacted strongly with proteins around 25, 40, 50, and 75 kDa. Proteins around 40 kDa detected by human serum were not recognized by hyperimmune rabbit serum. None of the target proteins were detected by uninfected control sera. Reactivities of five patients' sera with 4 different isolates of B. mandrillaris (2 strains of human and 2 strains of animal origins) revealed that patients' sera reacted slightly differently with different B. mandrillaris isolates, although major proteins of approximately 25, 50, and 75 kDa were present in all extracts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653740      PMCID: PMC3147352          DOI: 10.1128/CVI.05082-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  21 in total

1.  Isolation of Balamuthia amebas from the environment.

Authors:  Thelma H Dunnebacke; Frederick L Schuster; Shigeo Yagi; Gregory C Booton
Journal:  J Eukaryot Microbiol       Date:  2003       Impact factor: 3.346

2.  Notes from the field: transplant-transmitted Balamuthia mandrillaris --- Arizona, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-09-17       Impact factor: 17.586

3.  Amebic meningoencephalitis caused by Balamuthia mandrillaris (leptomyxid ameba) in a horse.

Authors:  H Kinde; G S Visvesvara; B C Barr; R W Nordhausen; P H Chiu
Journal:  J Vet Diagn Invest       Date:  1998-10       Impact factor: 1.279

4.  Axenic growth and drug sensitivity studies of Balamuthia mandrillaris, an agent of amebic meningoencephalitis in humans and other animals.

Authors:  F L Schuster; G S Visvesvara
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

5.  Serum antibodies to Balamuthia mandrillaris, a free-living amoeba recently demonstrated to cause granulomatous amoebic encephalitis.

Authors:  Z H Huang; A Ferrante; R F Carter
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

Review 6.  Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals.

Authors:  Frederick L Schuster; Govinda S Visvesvara
Journal:  Int J Parasitol       Date:  2004-08       Impact factor: 3.981

7.  Balamuthia mandrillaris, N. G., N. Sp., agent of amebic meningoencephalitis in humans and other animals.

Authors:  G S Visvesvara; F L Schuster; A J Martinez
Journal:  J Eukaryot Microbiol       Date:  1993 Jul-Aug       Impact factor: 3.346

Review 8.  Leptomyxid ameba, a new agent of amebic meningoencephalitis in humans and animals.

Authors:  G S Visvesvara; A J Martinez; F L Schuster; G J Leitch; S V Wallace; T K Sawyer; M Anderson
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

9.  Genotyping of Balamuthia mandrillaris based on nuclear 18S and mitochondrial 16S rRNA genes.

Authors:  Gregory C Booton; Jennifer R Carmichael; Govinda S Visvesvara; Thomas J Byers; Paul A Fuerst
Journal:  Am J Trop Med Hyg       Date:  2003-01       Impact factor: 2.345

10.  Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases.

Authors:  Thomas R Deetz; Mark H Sawyer; Glenn Billman; Frederick L Schuster; Govinda S Visvesvara
Journal:  Clin Infect Dis       Date:  2003-10-17       Impact factor: 9.079

View more
  4 in total

1.  Serologic survey for exposure following fatal Balamuthia mandrillaris infection.

Authors:  Brendan R Jackson; Zuzana Kucerova; Sharon L Roy; Glenda Aguirre; Joli Weiss; Rama Sriram; Jonathan Yoder; Rebecca Foelber; Steven Baty; Gordana Derado; Susan L Stramer; Valerie Winkelman; Govinda S Visvesvara
Journal:  Parasitol Res       Date:  2014-01-24       Impact factor: 2.289

Review 2.  Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease.

Authors:  Hongze Zhang; Xunjia Cheng
Journal:  Front Med       Date:  2021-11-26       Impact factor: 4.592

3.  Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain.

Authors:  Sharon L Roy; Jane T Atkins; Rosemaria Gennuso; Danny Kofos; Rama R Sriram; Thomas P C Dorlo; Teresa Hayes; Yvonne Qvarnstrom; Zuzana Kucerova; B Joseph Guglielmo; Govinda S Visvesvara
Journal:  Parasitol Res       Date:  2015-09-02       Impact factor: 2.289

4.  Management of granulomatous amebic encephalitis: Laboratory diagnosis and treatment.

Authors:  Subhash Chandra Parija; Kp Dinoop; Hrudya Venugopal
Journal:  Trop Parasitol       Date:  2015 Jan-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.